Procedure for unblinding if needed
Only the lead pharmacists will be unblinded for the implementation of treatment at the time of treatment. All participants can receive the treatment allocation at the end of the study. In case of an emergency where it is important to know the treatment received, the investigator and/or participant can reach out to the unblinded study personnel who will provide the unblinded data. Unblinding of investigators will only occur at the end of the study.